Skip to content

Market capitalization at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$11.64B+54.4%
Alkermes logo
AlkermesALKS
$5.89B+9.7%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$8.65B+52.0%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$1.93B+436%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$3.97B+51.0%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$3.8B+37.0%

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Enterprise value$1.55B-24.9%
P/E13.6×-1.6×
P/S2.2×-0.9×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Computed from the period-end share price: $1.62B.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s market capitalization?
Harmony Biosciences Holdings, Inc. (HRMY) reported market capitalization of $1.62B in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s market capitalization changed year-over-year?
Harmony Biosciences Holdings, Inc.'s market capitalization decreased by 14.9% year-over-year, from $1.9B to $1.62B.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s market capitalization?
Over 5 years (2020 to 2025), Harmony Biosciences Holdings, Inc.'s market capitalization has grown at a 0.9% compound annual growth rate (CAGR), from $2.06B to $2.16B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.